OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Surgery of the primary tumor improves survival in women with stage IV breast cancer in Southwest China
Yuxin Xie, Xingxing Lv, Chuanxu Luo, et al.
Medicine (2017) Vol. 96, Iss. 22, pp. e7048-e7048
Open Access | Times Cited: 17
Yuxin Xie, Xingxing Lv, Chuanxu Luo, et al.
Medicine (2017) Vol. 96, Iss. 22, pp. e7048-e7048
Open Access | Times Cited: 17
Showing 17 citing articles:
Breast cancer
Nadia Harbeck, Frédérique Penault‐Llorca, Javier Cortés, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 2284
Nadia Harbeck, Frédérique Penault‐Llorca, Javier Cortés, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 2284
Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model
Raziye Piranlioglu, EunMi Lee, Maria Ouzounova, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 91
Raziye Piranlioglu, EunMi Lee, Maria Ouzounova, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 91
Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: A meta-analysis
Ritika Gera, Hiba E. L. Hage Chehade, Umar Wazir, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 66
Ritika Gera, Hiba E. L. Hage Chehade, Umar Wazir, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 66
Primary tumor resection in stage IV breast cancer: A systematic review and meta-analysis
Weikai Xiao, Yutian Zou, Shaoquan Zheng, et al.
European Journal of Surgical Oncology (2018) Vol. 44, Iss. 10, pp. 1504-1512
Closed Access | Times Cited: 62
Weikai Xiao, Yutian Zou, Shaoquan Zheng, et al.
European Journal of Surgical Oncology (2018) Vol. 44, Iss. 10, pp. 1504-1512
Closed Access | Times Cited: 62
Unlocking survival benefits: primary tumor resection in De novo stage IV breast cancer patients
Dong Chen, Yue Wang, Yuancan Pan, et al.
Expert Review of Anticancer Therapy (2024), pp. 1-8
Closed Access | Times Cited: 3
Dong Chen, Yue Wang, Yuancan Pan, et al.
Expert Review of Anticancer Therapy (2024), pp. 1-8
Closed Access | Times Cited: 3
Nationwide Analysis of Treatment Patterns for Korean Breast Cancer Survivors Using National Health Insurance Service Data
Il Yong Chung, Jihyoun Lee, Suyeon Park, et al.
Journal of Korean Medical Science (2018) Vol. 33, Iss. 44
Open Access | Times Cited: 27
Il Yong Chung, Jihyoun Lee, Suyeon Park, et al.
Journal of Korean Medical Science (2018) Vol. 33, Iss. 44
Open Access | Times Cited: 27
Stereotactic body radiation therapy (SBRT) for the treatment of primary breast cancer in patients not undergoing surgery
Ewa Zabrocka, John Roberson, Collin Noldner, et al.
Advances in Medical Sciences (2024) Vol. 69, Iss. 1, pp. 29-35
Closed Access | Times Cited: 2
Ewa Zabrocka, John Roberson, Collin Noldner, et al.
Advances in Medical Sciences (2024) Vol. 69, Iss. 1, pp. 29-35
Closed Access | Times Cited: 2
Is there a role for locoregional treatment of the primary tumor in de novo metastatic breast cancer in the era of tailored therapies?
Elvire Pons‐Tostivint, Emily Alouani, Youlia Kirova, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 157, pp. 103146-103146
Open Access | Times Cited: 14
Elvire Pons‐Tostivint, Emily Alouani, Youlia Kirova, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 157, pp. 103146-103146
Open Access | Times Cited: 14
Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome
Vassiliki Kotoula, Kalliopi Tsakiri, Georgia-Angeliki Koliou, et al.
Clinical Breast Cancer (2018) Vol. 19, Iss. 2, pp. 113-125.e4
Closed Access | Times Cited: 11
Vassiliki Kotoula, Kalliopi Tsakiri, Georgia-Angeliki Koliou, et al.
Clinical Breast Cancer (2018) Vol. 19, Iss. 2, pp. 113-125.e4
Closed Access | Times Cited: 11
Operable breast cancer: How not to worsen the prognosis, especially in triple negative and stage II tumors
Rogério Agenor de Araújo, Felipe Andrés Cordero da Luz, Eduarda da Costa Marinho, et al.
Surgical Oncology (2021) Vol. 38, pp. 101596-101596
Closed Access | Times Cited: 7
Rogério Agenor de Araújo, Felipe Andrés Cordero da Luz, Eduarda da Costa Marinho, et al.
Surgical Oncology (2021) Vol. 38, pp. 101596-101596
Closed Access | Times Cited: 7
Prognosis and Treatment of Metastatic Breast Cancer From A Real-World Scenario in China: A Retrospective Cohort Study
Yuxin Xie, Ji Ma, Xueming Xia, et al.
Cancer Control (2022) Vol. 29
Open Access | Times Cited: 5
Yuxin Xie, Ji Ma, Xueming Xia, et al.
Cancer Control (2022) Vol. 29
Open Access | Times Cited: 5
Resection of primary lesion for patients with metastatic breast cancer: where are we now?
Qiancheng Hu, Xiaorong Zhong, Xu Liu, et al.
Chinese Clinical Oncology (2018) Vol. 7, Iss. 3, pp. 24-24
Open Access | Times Cited: 6
Qiancheng Hu, Xiaorong Zhong, Xu Liu, et al.
Chinese Clinical Oncology (2018) Vol. 7, Iss. 3, pp. 24-24
Open Access | Times Cited: 6
The Influence of Medical Comorbidities on Survival Disparities in a Multiethnic Group of Patients with De Novo Metastatic Breast Cancer
Lauren P. Wallner, Lie Hong Chen, Tiffany Hogan, et al.
Cancer Epidemiology Biomarkers & Prevention (2022) Vol. 31, Iss. 10, pp. 1935-1943
Closed Access | Times Cited: 3
Lauren P. Wallner, Lie Hong Chen, Tiffany Hogan, et al.
Cancer Epidemiology Biomarkers & Prevention (2022) Vol. 31, Iss. 10, pp. 1935-1943
Closed Access | Times Cited: 3
Long-Term Survival of Advanced Breast Cancer with Letrozole and Palbociclib: Can the Intent Change from Palliation to Cure?
Manikandan Dhanushkodi, V. Sridevi
Indian Journal of Gynecologic Oncology (2020) Vol. 18, Iss. 1
Closed Access | Times Cited: 1
Manikandan Dhanushkodi, V. Sridevi
Indian Journal of Gynecologic Oncology (2020) Vol. 18, Iss. 1
Closed Access | Times Cited: 1
The Value of Primary Tumor Resection among Different Treatment Methods in Stage IV Breast Cancer: Robust Evidence for Prognostic Benefit
Yuancan Pan, Dong Chen, Yue Wang, et al.
Research Square (Research Square) (2023)
Open Access
Yuancan Pan, Dong Chen, Yue Wang, et al.
Research Square (Research Square) (2023)
Open Access
Updated evidence of primary tumor resection in stage IV breast cancer: a systematic review and meta-analysis
Zacharoula Sidiropoulou, Ana Rita Martins, Patrícia Amaral, et al.
Journal of Cancer Metastasis and Treatment (2023)
Open Access
Zacharoula Sidiropoulou, Ana Rita Martins, Patrícia Amaral, et al.
Journal of Cancer Metastasis and Treatment (2023)
Open Access
